Signal active
Investment Firm
Overview
Alpha Wave is an investment company that has three main verticals; private equity, private credit, and public markets. The objective of the private equity partnerships is to invest in best-in-class venture and growth stage companies and endeavors to be helpful, long-term partners to these exceptional founders and management teams; credit, which includes direct private lending to businesses looking for funding solutions; and public markets in an uncorrelated strategy.
Alpha Wave has offices in New York, Miami, London, Monaco, Madrid, Abu Dhabi, Tel Aviv, Bangalore, Jakarta, and Sydney.
Highlights
2012
Financial Services
101-250
122
68
10
Late Stage Venture, Private Equity, Seed, Early Stage Venture
Private Equity Firm, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Alpha Wave Global, established in 2012 and headquartered in United States, North America., specializes in Late Stage Venture, Private Equity, Seed, Early Stage Venture investments across Social Media, Internet, Content, Enterprise Software, Financial Services, Venture Capital, Finance, Mobile, Apps, Transportation. The organization boasts a portfolio of 121 investments, with an average round size of $106.0M and 10 successful exits. Their recent investments include VerSe Innovation, Omidyar Network, Matrix Partners India, Ola, RNT Capital. The highest investment round they participated in was $1162.5B. Among their most notable exits are VerSe Innovation and Omidyar Network. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
122
4
68
10
Investments
122
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Mar 21, 2024 | LENZ Therapeutics | Health Care | 53.5M |
May 08, 2024 | - | - | 13.2M |
May 13, 2024 | Mitra Chem | Manufacturing | null |
Jun 18, 2024 | - | - | 190.0M |
Exits
10
Funding Timeline
122
0
2
Funding Rounds
122
Alpha Wave Global has raised 122 rounds. Their latest funding was raised on Jun 18, 2024 from a Series B - Marea Therapeutics round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Mar 21, 2024 | Post-IPO Equity - LENZ Therapeutics | - | 53.5M | - |
May 08, 2024 | Venture Round - Stanza Living | - | 13.2M | - |
May 13, 2024 | Series B - Mitra Chem | - | 0 | - |
Jun 18, 2024 | Series B - Marea Therapeutics | - | 190.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.